Clinical Trial Update: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing Fludarabine and Busulfan versus Fludarabine, Busulfan plus Total Body Irradiation in patients with myeloid malignancies, in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)
• Total Body Irradiation

Snippet

Sponsor: Hackensack Meridian Health | Conditions: Myeloid Malignancies, Acute Myelogenous Leukemia | Phase 3 | Status: TERMINATED | Results posted: 2022-12-16